CHEBI:43871 - fasudil

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name fasudil
ChEBI ID CHEBI:43871
Definition An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
more structures >>
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C14H17N3O2S
Net Charge 0
Average Mass 291.370
Monoisotopic Mass 291.10415
InChI InChI=1S/C14H17N3O2S/c18-20(19,17-9-2-6-15-8-10-17)14-4-1-3-12-11-16-7-5-13(12)14/h1,3-5,7,11,15H,2,6,8-10H2
InChIKey NGOGFTYYXHNFQH-UHFFFAOYSA-N
SMILES O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2
Roles Classification
Biological Role(s): EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of non-specific serine/threonine protein kinase (EC 2.7.11.1), a kinase enzyme involved in phosphorylation of hydroxy group of serine or threonine.
calcium channel blocker
One of a class of drugs that acts by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools.
Application(s): geroprotector
Any compound that supports healthy aging, slows the biological aging process, or extends lifespan.
vasodilator agent
A drug used to cause dilation of the blood vessels.
nootropic agent
Any compound that improves mental functions such as cognition, memory, intelligence, motivation, attention, and concentration.
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
antihypertensive agent
Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing fasudil (CHEBI:43871) has role antihypertensive agent (CHEBI:35674)
fasudil (CHEBI:43871) has role calcium channel blocker (CHEBI:38215)
fasudil (CHEBI:43871) has role EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor (CHEBI:50925)
fasudil (CHEBI:43871) has role geroprotector (CHEBI:176497)
fasudil (CHEBI:43871) has role neuroprotective agent (CHEBI:63726)
fasudil (CHEBI:43871) has role nootropic agent (CHEBI:66980)
fasudil (CHEBI:43871) has role vasodilator agent (CHEBI:35620)
fasudil (CHEBI:43871) is a N-sulfonyldiazepane (CHEBI:46946)
fasudil (CHEBI:43871) is a isoquinolines (CHEBI:24922)
fasudil (CHEBI:43871) is conjugate base of fasudil(1+) (CHEBI:180694)
Incoming fasudil(1+) (CHEBI:180694) is conjugate acid of fasudil (CHEBI:43871)
IUPAC Name
5-(1,4-diazepan-1-ylsulfonyl)isoquinoline
INNs Sources
fasudil WHO MedNet
fasudil WHO MedNet
fasudil WHO MedNet
fasudilum WHO MedNet
Synonyms Sources
1-(5-isoquinolinesulfonyl)homopiperazine ChemIDplus
5-[(hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]isoquinoline ChEBI
AT 877 ChemIDplus
AT-877 ChemIDplus
HA 1077 ChemIDplus
HA-1077 DrugCentral
HA1077 ChemIDplus
hexahydro-1-(5-isoquinolinesulfonyl)-1H-1,4-diazepine ChEBI
hexahydro-1-(5-isoquinolinylsulfonyl)-1H-1,4-diazepine ChemIDplus
ZK-258594 DrugBank
Manual Xrefs Databases
1132 DrugCentral
3426 ChemSpider
D07941 KEGG DRUG
DB08162 DrugBank
Fasudil Wikipedia
HMDB0252175 HMDB
LSM-3715 LINCS
M77 PDBeChem
View more database links
Registry Number Type Source
103745-39-7 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
22363408 PubMed citation Europe PMC
31670380 PubMed citation Europe PMC
31894538 PubMed citation Europe PMC
32076619 PubMed citation Europe PMC
32192772 PubMed citation Europe PMC
32396545 PubMed citation Europe PMC
32462797 PubMed citation Europe PMC
32650141 PubMed citation Europe PMC
32685556 PubMed citation Europe PMC
32727014 PubMed citation Europe PMC
32770034 PubMed citation Europe PMC
33222274 PubMed citation Europe PMC
33341946 PubMed citation Europe PMC
33357780 PubMed citation Europe PMC
33433459 PubMed citation Europe PMC
33436060 PubMed citation Europe PMC
33527868 PubMed citation Europe PMC
33832886 PubMed citation Europe PMC
33838256 PubMed citation Europe PMC
33907042 PubMed citation Europe PMC
34078832 PubMed citation Europe PMC
34156163 PubMed citation Europe PMC
34239271 PubMed citation Europe PMC
34359853 PubMed citation Europe PMC
34384329 PubMed citation Europe PMC
34542824 PubMed citation Europe PMC
34557101 PubMed citation Europe PMC
34558416 PubMed citation Europe PMC
Last Modified
08 October 2021